Latest Posts

Medicines Excitement in the Netherlands – New Health Minister announces firm action on...

The new Minister of Health of the Netherlands, Bruno Bruins, came in guns blazing when he put the pharmaceutical industry on notice and announced...

Modifier la législation européenne pour mettre en œuvre la licence d’office en France

Selon le Dr Thierry Philip, Président de l’institut Curie, la hausse des prix des nouveaux traitements contre le cancer « est devenue intenable. » L’augmentation croissante du prix...

Medicines Law & Policy expert wins Prescrire Prize for “major reference work” on IP...

PARIS, France: La Revue Prescrire, a French journal for healthcare professionals, has chosen “Private Patents and Public Health” — a 2016 book written by...

Pharmaceutical Pricing Hostages

Ireland seems to be the stage of some of the most bizarre pharmaceutical company behaviour these days. This month, the pharmaceutical company CSL Behring...

Dolutegravir Patent Licences Can Provide Access To All

This year the World Health Organization (WHO) added dolutegravir, an antiretroviral medicine for the treatment of HIV infection, to its Model List of Essential...
video

“The diseases were in the South and the drugs were in the North”: Ellen...

Ellen 't Hoen discusses the HIV epidemic in the 90's, which hit sub-Saharan Africa particularly hard, and was exacerbated by the lack of availability...